• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2021 年孟加拉国 SARS-CoV-2 德尔塔变异株的分子和血清学特征。

Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.

机构信息

Department of Virology, Dhaka Medical College Hospital, Dhaka 1000, Bangladesh.

GenExpress Gesellschaft für Proteindesign GmbH, Eresburgstraße 22-23 D, 12103 Berlin, Germany.

出版信息

Viruses. 2021 Nov 19;13(11):2310. doi: 10.3390/v13112310.

DOI:10.3390/v13112310
PMID:34835116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8623815/
Abstract

Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance ( = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.

摘要

新的 SARS-CoV-2 变体正在以惊人的速度出现。德尔塔变体和其他关切变体 (VoC) 携带刺突 (S)-蛋白突变,有可能逃避保护性免疫,在 COVID-19 疫苗接种后引发突破性感染,并引发未来的 COVID-19 大流行浪潮。为了在孟加拉国识别 SARS-CoV-2 变体,对达卡 COVID-19 感染 RT-PCR 阳性的患者进行 RT-PCR 熔解曲线分析,以筛选刺突蛋白突变。为了评估抗 SARS-CoV-2 抗体反应,通过 ELISA 测量抗 S-蛋白 IgA 和 IgG 以及抗 N-蛋白 IgG 的水平。在总共 36 个 RT-PCR 阳性样本(75%)中,有 27 个被鉴定为德尔塔变体,其中一个携带额外的 Q677H 突变,两个在基因组序列中 23029 位(与武汉-Hu-1 参考 NC_045512 相比)有单核苷酸取代。三个(8.3%)被鉴定为 beta 变体,两个(5.5%)被鉴定为 alpha 变体,三个(8.3%)被鉴定为具有 B.1.1.318 谱系,一个样本被鉴定为 eta 变体(B.1.525)携带额外的 V687L 突变。德尔塔变体的病毒载量较高(较低的 Cp 值)的趋势与 alpha 和 beta 变体相比具有边缘统计学意义(=0.045)。需要进行具有更大孟加拉国队列的前瞻性研究,以确认 S-蛋白突变的出现及其与自然感染和接种疫苗者潜在突破的抗体反应的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0a63bc4ca5d4/viruses-13-02310-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0551ef0c82ef/viruses-13-02310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/a1a7028c3834/viruses-13-02310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0db29f56df4a/viruses-13-02310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/6e582102798e/viruses-13-02310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0a63bc4ca5d4/viruses-13-02310-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0551ef0c82ef/viruses-13-02310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/a1a7028c3834/viruses-13-02310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0db29f56df4a/viruses-13-02310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/6e582102798e/viruses-13-02310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9148/8623815/0a63bc4ca5d4/viruses-13-02310-g005.jpg

相似文献

1
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.2021 年孟加拉国 SARS-CoV-2 德尔塔变异株的分子和血清学特征。
Viruses. 2021 Nov 19;13(11):2310. doi: 10.3390/v13112310.
2
Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection.快速定量检测人类针对新型冠状病毒 SARS-CoV-2 及其变异株的抗体,这些抗体来自疫苗接种和感染。
Microbiol Spectr. 2021 Oct 31;9(2):e0089021. doi: 10.1128/Spectrum.00890-21. Epub 2021 Sep 29.
3
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.新型冠状病毒感染后长达13个月的抗体反应演变及再次感染风险。
EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27.
4
A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.一种带有条形码的流式细胞术检测方法,用于探索针对 SARS-CoV-2 刺突及其变体的抗体反应。
Front Immunol. 2021 Sep 23;12:730766. doi: 10.3389/fimmu.2021.730766. eCollection 2021.
5
Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.用于评估接种后 SARS-CoV-2 抗体反应的血清学检测方法。
Microbiol Spectr. 2021 Oct 31;9(2):e0073321. doi: 10.1128/Spectrum.00733-21. Epub 2021 Sep 29.
6
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
7
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.新冠肺炎患者血清中数月来持续存在对 SARS-CoV-2 的中和活性。
Viruses. 2020 Nov 27;12(12):1357. doi: 10.3390/v12121357.
8
Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.开发扩增抑制突变系统-实时荧光定量 RT-PCR 检测方法,快速灵敏地筛查关注的 SARS-CoV-2 变异株。
Microbiol Spectr. 2022 Feb 23;10(1):e0143821. doi: 10.1128/spectrum.01438-21. Epub 2022 Jan 5.
9
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.健康工作者接种一剂 SARS-CoV-2 疫苗后,使用六种自动化 SARS-CoV-2 抗体检测试剂的血清学反应。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115486. doi: 10.1016/j.diagmicrobio.2021.115486. Epub 2021 Jul 10.
10
Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.日本一种新型自动化化学发光抗SARS-CoV-2 IgM和IgG抗体检测系统的验证,该系统可同时检测N蛋白和S蛋白。
PLoS One. 2021 Mar 4;16(3):e0247711. doi: 10.1371/journal.pone.0247711. eCollection 2021.

引用本文的文献

1
SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned.孟加拉国的 SARS-CoV-2 变异株和 COVID-19:经验教训。
Viruses. 2024 Jul 4;16(7):1077. doi: 10.3390/v16071077.
2
The severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) omicron sub-variants in Bangladesh cause mild COVID-19 and associate with similar antibody responses irrespective of natural infection or vaccination history.孟加拉国的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚变体导致轻度新冠肺炎,且无论自然感染史或疫苗接种史如何,其抗体反应相似。
Heliyon. 2024 May 10;10(10):e31011. doi: 10.1016/j.heliyon.2024.e31011. eCollection 2024 May 30.
3

本文引用的文献

1
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population.一般人群中针对自然感染 SARS-CoV-2 的刺突抗体反应。
Nat Commun. 2021 Oct 29;12(1):6250. doi: 10.1038/s41467-021-26479-2.
2
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株的传播事件揭示了多起疫苗突破性感染病例。
BMC Med. 2021 Oct 1;19(1):255. doi: 10.1186/s12916-021-02103-4.
3
Emergence of highly infectious SARS-CoV-2 variants in Bangladesh: the need for systematic genetic surveillance as a public health strategy.
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
急性 SARS-CoV-2 感染期间宿主内进化动态和组织隔室化。
J Virol. 2024 Jan 23;98(1):e0161823. doi: 10.1128/jvi.01618-23. Epub 2024 Jan 4.
4
Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects.灭活病毒疫苗接种、康复和突破性感染受试者中 SARS-CoV-2 特异性体液反应的差异。
J Infect Dis. 2023 Oct 3;228(7):857-867. doi: 10.1093/infdis/jiad320.
5
SARS-CoV-2 viral variants can rapidly be identified for clinical decision making and population surveillance using a high-throughput digital droplet PCR assay.SARS-CoV-2 病毒变异株可通过高通量数字液滴 PCR 检测方法快速鉴定,以便为临床决策和人群监测提供依据。
Sci Rep. 2023 May 10;13(1):7612. doi: 10.1038/s41598-023-34188-7.
6
Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Delta或Omicron变种的孟加拉国患者的新冠病毒疾病(COVID-19)临床表现及抗体反应
Vaccines (Basel). 2022 Nov 18;10(11):1959. doi: 10.3390/vaccines10111959.
7
Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study.接种疫苗者感染 SARS-CoV-2 德尔塔变异株的临床和免疫反应特征:一项回顾性研究。
J Zhejiang Univ Sci B. 2022 Nov 15;23(11):899-914. doi: 10.1631/jzus.B2200054.
8
Association of food habit with the COVID-19 severity and hospitalization: A cross-sectional study among the recovered individuals in Bangladesh.饮食与 COVID-19 严重程度和住院的关联:孟加拉国康复人群中的横断面研究。
Nutr Health. 2022 Dec;28(4):771-782. doi: 10.1177/02601060221124068. Epub 2022 Sep 6.
孟加拉国出现高传染性的新冠病毒变异株:作为公共卫生策略进行系统基因监测的必要性。
Trop Med Health. 2021 Sep 1;49(1):69. doi: 10.1186/s41182-021-00360-w.
4
Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection. Spike 免疫球蛋白 G 抗体对 SARS-CoV-2 在既往感染的医护人员中的持久性。
JAMA Netw Open. 2021 Aug 2;4(8):e2123256. doi: 10.1001/jamanetworkopen.2021.23256.
5
Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity.抗 SARS-CoV-2 IgG ELISA 定量检测与中和活性的相关性。
J Med Virol. 2022 Jan;94(1):388-392. doi: 10.1002/jmv.27287. Epub 2021 Aug 31.
6
Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach.SARS-CoV-2 疫苗可及性的决定因素:初步探讨。
Int J Equity Health. 2021 Aug 14;20(1):183. doi: 10.1186/s12939-021-01520-4.
7
Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains.SARS-CoV-2 的传播率和疫苗接种率影响着疫苗耐药株的命运。
Sci Rep. 2021 Jul 30;11(1):15729. doi: 10.1038/s41598-021-95025-3.
8
Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave.孟加拉国报告在其公民中发现新冠病毒德尔塔变种:应对潜在大规模第三波疫情的可行动事项。
Infect Prev Pract. 2021 Sep;3(3):100159. doi: 10.1016/j.infpip.2021.100159. Epub 2021 Jun 29.
9
Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh.孟加拉国新冠疫情第一波结束阶段收集的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的基因组监测
Microbiol Resour Announc. 2021 Jul 22;10(29):e0049621. doi: 10.1128/MRA.00496-21.
10
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.